Literature DB >> 32480049

Stem Cell Membrane-Coated Au-Ag-PDA Nanoparticle-Guided Photothermal Acne Therapy.

Tianqi Meng1, Rihua Jiang1, Shiyi Wang1, Jing Li2, Fuqiang Zhang2, Jeung-Hoon Lee3, Jinlan Jiang4, Mingji Zhu5.   

Abstract

The polydopamine coating on Au-Ag nanoparticles (Au-Ag-PDA) possess excellent photothermal conversion efficiency after absorbing near-infrared laser light. After the stem cell membrane (STCM) encapsulates Au-Ag-PDA (Au-Ag-PDA@STCM), the nanoparticles (NPs) exhibit less cytotoxicity, and further optimizing their efficiency in photothermal therapy. The photothermal activity of Au-Ag-PDA@STCM has not yet been reported. Therefore, in this study, the sebaceous gland cell line SZ95 and the golden hamsters were used to observe the photothermal effects of the Au-Ag-PDA@STCM. SZ95 cells were treated with various concen-trations of Au-Ag-PDA@STCM NPs. The photothermal effect on cell proliferation was analyzed after irradiating the cells with a 808 nm laser. After laser treatment of golden hamsters, the flank organs were observed at 4 different time points. Histological analysis was performed to observe tissue damage. The results suggest that Au-Ag-PDA@STCM NPs significantly inhibited the proliferation of sebaceous gland cells in vitro, and reduced the size of sebaceous glands and sebum secretion in vivo. Therefore, NPs can be used to treat acne by thermally injuring sebaceous gland cells.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  acne; nanoparticle; photothermal therapy; stem cell membrane

Year:  2020        PMID: 32480049     DOI: 10.1016/j.colsurfb.2020.111145

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  1 in total

1.  Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis.

Authors:  Kangkang Ying; Yifeng Zhu; Jianqin Wan; Chenyue Zhan; Yuchen Wang; Binbin Xie; Peirong Xu; Hongming Pan; Hangxiang Wang
Journal:  Bioact Mater       Date:  2022-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.